ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Responses To Control Grants Guidelines Pour Into NCI, Some From Grantsmen “Old Pros”

November 23, 1974

NCI Takes Action Against Investigators Who Gave Drug Without An IND; M.D. Anderson Contract Canceled

August 28, 1981

NCI RFA: Basic Biobehavioral Research

August 6, 1999

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

April 11, 2008

Niederhuber Leads AACI

November 2, 2001

NCI May Seek Cuts In R01s, P01s If Congress Approves Rescission

January 30, 1981